MEDecision Schedules Release of Second Quarter 2008 Results
July 17 2008 - 7:30AM
Business Wire
MEDecision, Inc. (Nasdaq: MEDE), a leading provider of
collaborative health care management solutions, announced today
that it will release financial results for the three months ended
June 30, 2008 before the market opens on Thursday, July 24, 2008
with an accompanying conference call at 8:30 a.m. EDT. A live Web
cast of the conference call will be available online on the
company's corporate Web site at www.MEDecision.com. The dial-in
numbers are (877) 407-0784 for domestic callers and (201) 689-8560
for international callers. After the live Web cast, the call will
remain available on MEDecision's Web site until August 7, 2008. In
addition, a telephonic replay of the call will be available until
July 31, 2008. The replay dial-in numbers are (877) 660-6853 for
domestic callers and (201) 612-7415 for international callers.
Please use account number 3055 and conference ID number 291630.
About MEDecision MEDecision offers collaborative health care
management solutions that provide a simplified and smart way to
manage the health of members and member populations which can
improve the quality and affordability of care. Based on
state-of-the-art technology, MEDecision's solutions include
Alineo�, a collaborative health care management platform for
managing case, disease and utilization management and Nexalign�, a
collaborative health care information exchange service. MEDecision
believes that, in the aggregate, its health care payer customers
insure or manage care for approximately one in every six people in
the U.S. with health insurance. For more information, please visit
www.MEDecision.com. Forward-Looking Statements This release
contains, and the conference call will contain, forward-looking
statements within the meaning of the "safe harbor" provisions of
the federal securities laws, including, without limitation,
estimates of revenue, the impact on revenue derived from recurring
fees and services, and statements concerning the company's term
license deal pipeline and the company's expectations regarding its
subscriptions and transactions business, Collaborative Health Care
Management solutions and Clinical Summaries. These forward-looking
statements are subject to risks and uncertainties that could cause
actual events or results to differ materially from such statements.
The company's actual results could differ materially from those
expressed or implied by these forward-looking statements as a
result of various factors, including, but not limited to, the
company's completion of its quarter closing process and the
completion of the year-end audit by the company's independent
auditors and the various risks described in the "Risk Factors"
section and elsewhere in the company's Annual Report on Form 10-K
as filed with the Securities and Exchange Commission (SEC) on March
28, 2008 and the company's Quarterly Report on Form 10-Q as filed
with the SEC on November 14, 2007. MEDecision undertakes no
obligation to update publicly any forward-looking statements for
any reason, even if new information becomes available or other
events occur in the future. MEDecision is a trademark of
MEDecision, Inc. The MEDecision logo and product names are also
trademarks or registered trademarks of MEDecision, Inc. MEDE-E
Medecision (MM) (NASDAQ:MEDE)
Historical Stock Chart
From Oct 2024 to Nov 2024
Medecision (MM) (NASDAQ:MEDE)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Medecision (MM) (NASDAQ): 0 recent articles
More MEDecision, Inc. News Articles